Jason Haas, CFO: Syros Pharmaceuticals SYRS Sell · Filed 24/11/20

Trade details

Type: Insider sale
Amount: $28,938.63
Shares · price: 137,803 sh · $0.21 a share
Held after: 0 sh
Stock: Syros Pharmaceuticals SYRS
Person: Jason HaasCFO
Trade date: 24/11/18
Filed: 24/11/20
Days to filing: 2 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Syros Pharmaceuticals trades, last 26 weeks

What else happened in Syros Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/10/19~24/12/18

Jason Haas's recent trades

Jason HaasDirector
Planned saleLigand Pharmaceuticals
Planned sale
Ligand Pharmaceuticals
LGND
$2.1M
7,138 sh
$2.1M
Filed 08/12
Traded 08/12
Jason HaasDirector
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$886.3K
3,461 sh
$886.3K
Filed 06/15
Traded 06/12
Jason HaasDirector
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$765K
3,000 sh
$765K
Filed 06/15
Traded 06/12
Jason HaasDirector
Planned saleLigand Pharmaceuticals
Planned sale
Ligand Pharmaceuticals
LGND
$1.7M
6,461 sh
$1.7M
Filed 06/12
Traded 06/12
Jason HaasCFO
BuyOdyssey Therapeutics
Buy
Odyssey Therapeutics
ODTX
$20K
1,000 sh
$20K
Filed 05/11
Traded 05/08